z-logo
Premium
Carrier‐mediated efflux of [ 3 H] dopamine and [ 3 H]1‐methyl‐4‐phenylopyridine: Effects of ascorbic acid
Author(s) -
Debler Edumund A.,
Sershen Henry,
Hashim Audrey,
Lajtha Abel,
Reith Maarten E. A.
Publication year - 1991
Publication title -
synapse
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.809
H-Index - 106
eISSN - 1098-2396
pISSN - 0887-4476
DOI - 10.1002/syn.890070203
Subject(s) - dopamine , mazindol , ascorbic acid , efflux , chemistry , d 1 , biochemistry , endocrinology , receptor , biology , food science
The carrier‐mediated efflux of [ 3 H]1‐methyl‐4‐phenylpyridine (MPP + ) and [ 3 H] dopamine was examined in mouse striatal synaposomal p 2 fractions. Although the two compound are transported by the same carrier, the translocation of the carrier–ligand complex is more rapid with MPP + than with dopamine. With dopamine‐stimulated efflux of preloaded [ 3 H] dopamine, externally present dopamine at concentration of 1.3 μM reduced the intrasynaprosomal concentration of [ 3 H] dopamine by 50% (the EC R value) with 8 min of incubation. The EC R value of dopamine in promoting the efflux of [ 3 H]MPP + was only 0.15 μM. Similarly [ 3 H] ascorbic acid was weaker in enhancing the efflux of dopamine (EC R > 2000 μM) than that of [ 3 H] MPP + (EC R = 567 μM). This effect of ascorbic acid on the efflux of [ 3 H]MPP + was attenuated by mazindol, a blocker of dopamine uptake. It is proposed that ascorbic acid has a neuromodulatory role involving changes at the level of carrier‐membrane translocation and/or orientation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom